Vitamins and vitamin-like nutrients for prevention of human diseases

Vitamins in the Prevention of Human Diseases

Volumn , Issue , 2011, Pages 515-560

  Shearer, Martin J ^a   Gorska, Renata ^a   Harrington, Dominic J ^a   Schurgers, Leon J ^b   Newman, Paul ^c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881714253     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1515/9783110214499     Document Type: Chapter

References (180)

1. Allison AC, Danger of vitamin K to newborn. Lancet 1955;265: 669.
2. Ansell JE, Kumar R, Deykin D, The spectrum of vitamin K deficiency. J Am Med Assoc 1977;238: 40-2.
3. Atkins GJ, Welldon KJ, Wijenayaka AR, Bonewald LF, Findlay DM, Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by γ-carboxylationdependent and -independent mechanisms. Am J Physiol Cell Physiol 2009;297: C1358-67.
4. Azuma K, Urano T, Ouchi Y, et al., Vitamin K2 suppresses proliferation and motility of hepatocellular carcinoma cells by activating steroid and xenobiotic receptor. Endocr J 2009;56: 843-9.
5. Bhanchet P, Tuchinda S, Hathirat P, Visudhiphan P, Bhamaraphavati N, Bukkavesa S, A bleeding syndrome in infants due to acquired prothrombin complex deficiency: a survey of 93 affected infants. Clin Pediatr (Phila) 1977;16: 992-8.
6. Bjornsson TD, Meffin PJ, Swezey SE, Blaschke TF, Effects of clofibrate and warfarin alone and in combination on the disposition of vitamin K1. J Pharmacol Exp Ther 1979;210: 322-6.
7. Bolton-Smith C, McMurdo ME, Paterson CR, Mole PA, Harvey JM, Fenton ST, Prynne CJ, MishraGD, Shearer MJ, Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. J Bone Miner Res 2007;22: 509-19.
8. Booth SL, Al Rajabi A, Determinants of vitamin K status in humans. Vitam Horm 2008;78: 1-22.
9. Booth SL, Suttie JW, Dietary intake and adequacy of vitamin K. J Nutr 1998;128: 785-8.
10. Booth SL, Tucker KL, Chen H et al., Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 2000;71: 1201-8.
11. Booth SL, Broe KE, Gagnon DR et al., Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr 2003;77: 512-6.
12. Booth SL, Broe KE, Peterson JW, Cheng DM, Dawson-Hughes B, Gundberg CM, Cupples LA, Wilson PW, Kiel DP, Associations between vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metab 2004;89: 4904-9.
13. Booth SL, Dallal G, Shea MK, Gundberg C, Peterson JW, Dawson-Hughes B, Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 2008;93: 1217-23.
14. Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G, Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 1998;23: 187-96.
15. Bostrom K, Tsao D, Shen S, Wang Y, Demer LL, Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 2001;276: 14044-52.
16. Bouzahzah B, Nishikawa Y, Simon D, et al., Growth control and gene expression in a new hepatocellular carcinoma cell line, Hep40: Inhibitory actions of vitamin K. J Cell Physiol 1995;165: 459-67.
17. Braam LA, Knapen MH, Geusens P, Brouns F, Hamulyak K, Gerichhausen MJ, Vermeer C, Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 2003;73: 21-6.
18. Braam LA, Hoeks AP, Brouns F, Hamulyak K, Gerichhausen MJ, Vermeer C, Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Haemost 2004;91: 373-80.
19. Brenner DJ, Hall EJ, Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007;357: 2277-84.
20. Caraballo PJ, Gabriel SE, Castro MR, Atkinson EJ, Melton LJ 3rd, Changes in bone density after exposure to oral anticoagulants: a meta-analysis. Osteoporos Int 1999;9: 441-8.
21. Carrie I, Portoukalian J, Vicaretti R, et al., Menaquinone-4 concentration is correlated with sphingolipid concentrations in rat brain. J Nutr 2004;134: 167-72.
22. Cheung AM, Tile L, Lee Y, et al., Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med 2008;5: e196.
23. Chlebowski RT, DietrichM, Akman S, et al., Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation. Cancer Treat Rep 1985;69: 527-32.
24. Chu PH, Huang TW, Williams J, Stafford DW, Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2. Proc Natl Acad Sci USA 2006;103: 19308-13.
25. Chuansumrit A, Isarangkura P, Hathirat P, Vitamin K Study Group, Vitamin K deficiency bleeding in Thailand: a 32-year history. Southeast Asian J Trop Med Public Health 1998;29: 649-54.
26. Cocchetto DM, Miller DB, Miller LL, et al., Behavioral perturbations in the vitamin K-deficient rat. Physiol Behav 1985;34: 727-34.
27. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ, Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2006;166: 1256-61.
28. COMA, Dietary reference values for food energy and nutrients for the United Kingdom. Report of the panel on dietary reference values, committee on medical aspects of food and nutrition policy. London: HMSO; 1991.
29. Conly JM, Stein K, Quantitative and qualitative measurements of K vitamins in human intestinal contents. Am J Gastroenterol 1992;87: 311-6.
30. Conway SP, Wolfe SP, Brownlee KG, White H, Oldroyd B, Truscott JG, Harvey JM, Shearer MJ, Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. Pediatrics 2005;115: 1325-31.
31. Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J, Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem 2008;283: 17991-8001.
32. Cranenburg EC, Vermeer C, Koos R, Boumans ML, Hackeng TM, Bouwman FG, Kwaijtaal M, Brandenburg VM, Ketteler M, Schurgers LJ, The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 2008;45: 427-36.
33. Cranenburg EC, Brandenburg VM, Vermeer C, Stenger M, Muhlenbruch G, Mahnken AH, Gladziwa U, Ketteler M, Schurgers LJ, Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients. Thromb Haemost 2009;101: 359-66.
34. Dowd P, Hershline R, Ham SW, Naganathan S, Vitamin K and energy transduction: a base strength amplification mechanism. Science 1995;269: 1684-91.
35. Ducy P, Desbois C, Boyce B, et al., Increased bone formation in osteocalcin-deficient mice. Nature 1996;382: 448-52.
36. Elston TN, Dudley JM, Shearer MJ, Schey SA, Vitamin K prophylaxis in high-dose chemotherapy. Lancet 1995;345: 1245.
37. Erkkilä AT, Lichtenstein AH, Dolnikowski GG, Grusak MA, Jalbert SM, Aquino KA, Peterson JW, Booth SL, Plasma transport of vitamin K in men using deuterium-labeled Collard greens. Metabolism 2004;53: 215-21.
38. Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA, Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 1999;69: 74-9.
39. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, manganese, molybdenum, nickel, silicon, vanadium and zinc. Washington, DC: National Academy Press; 2001.
40. Funato K, Miyazawa K, Yaguchi M, et al., Combination of 22-oxa-1, 25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells. Leukemia 2002;16: 1519-27.
41. Furie B, Bouchard BA, Furie BC, Vitamin K-dependent biosynthesis of γ-carboxyglutamic acid. Blood 1999;93: 1798-808.
42. Gast GC, de Roos NM, Sluijs I, Bots ML, Beulens JW, Geleijnse JM, Witteman JC, Grobbee DE, Peeters PH, van der Schouw YT, A high menaquinone intake reduces the incidence of coronary heart disease in women. Nutr Metab Cardiovasc Dis 2009;19: 504-10.
43. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC, Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004;134: 3100-5.
44. Greer FR, Marshall S, Cherry J, Suttie, JW, Vitamin K status of lactating mothers, human milk, and breast-feeding infants. Pediatrics 1991;88: 751-6.
45. Habu D, Shiomi S, Tamori A, et al., Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. J AmMed Assoc 2004;292: 358-61.
46. Hara K, Akiyama Y, NakamuraT, et al., The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain. Bone 1995;16: 179-84.
47. Haroon Y, Shearer MJ, Rahim S, Gunn WG, McEnery G, Barkhan P, The content of phylloquinone (vitamin K1) in human milk, cows' milk and infant formula foods determined by high-performance liquid chromatography. J Nutr 1982;112: 1105-17.
48. Harrington DJ, Soper R, Edwards C, Savidge GF, Hodges SJ, Shearer MJ, Determination of the urinary aglycone metabolites of vitamin K by HPLC with redox-mode electrochemical detection. J Lipid Res 2005;46: 1053-60.
49. Harrington DJ, Booth SL, Card DJ, Shearer MJ, Excretion of the urinary 5C- and 7C-aglycone metabolites of vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. J Nutr 2007;137: 1763-8.
50. Harrington DJ, Western H, Seton-Jones C, Rangarajan S, Beynon T, Shearer MJ, A study of the prevalence of vitamin K deficiency in patients with cancer referred to a hospital palliative care team and its association with abnormal haemostasis. J Clin Pathol 2008;61: 537-40.
51. 1 in osteoporosis. J Clin Endocrinol Metab 1985;60: 1268-9.
52. Hauschka PV, Lian JB, Gallop PM, Direct identification of the calcium-binding amino acid, γ-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci USA 1975;72: 3925-3929.
53. Hiruma Y, Nakahama K, Fujita H, et al., Vitamin K2 and geranylgeraniol, its side chain component, inhibited osteoclast formation in a different manner. Biochem Biophys Res Commun 2004;314: 24-30.
54. Hitomi M, Yokoyama F, Kita Y, et al., Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. Int J Oncol 2005;26: 713-20.
55. Hoang QQ, Sicheri F, Howard AJ, Yang DSC, Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 2003;425: 977-80.
56. Hodges SJ, Pilkington MJ, Shearer MJ, Bitensky L, Chayen J, Age-related changes in the circulating levels of congeners of vitamin K2, menaquinone-7 and menaquinone-8. Clin Sci (Lond) 1990;78: 63-6.
57. Hodges SJ, Pilkington MJ, Stamp TCB, Catterall A, Shearer MJ, Bitensky L, Chayen J, Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 1991;12: 387-9.
58. Hodges SJ, Akesson K, Vergnaud P, Obrant K, Delmas PD, Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res 1993b;8: 1241-5.
59. 2 in human cortical and trabecular bone. J Bone Min Res 1993a;8: 1005-8.
60. Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL, Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol 2010;5: 590-7.
61. 3. J Lab Clin Med 1974b;83: 648-56.
62. 3 small intestinal transport. Am J Physiol 1974a;226: 1516-22.
63. Ichikawa T, Horie-Inoue K, Ikeda K, et al., Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. J Biol Chem 2006;281: 16927-34.
64. 2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells. J Mol Endocrinol 2007;39: 239-47.
65. Ide Y, Zhang H, Hamajima H, et al., Inhibition of matrix metalloproteinase expression by menetetrenone, a vitamin K2 analogue. Oncol Rep 2009;22: 599-604.
66. Kalkwarf HJ, Khoury JC, Bean J, Elliot JG, Vitamin K, bone turnover, and bone mass in girls. Am J Clin Nutr 2004;80: 1075-80.
67. 2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun 1996;220: 515-9.
68. Kaptoge S, Dalzell N, WelchA, Shearer MJ, Khaw KT, Reeve J, Vitamin K and fracture risk: an effect on bone width not BMD? J Bone Miner Res 2005;20: 1293.
69. Katagiri M, Hakeda Y, Chikazu D, et al., Mechanism of stimulation of osteoclastic bone resorption through Gas6/Tyro 3, a receptor tyrosine kinase signaling, in mouse osteoclasts. J Biol Chem 2001;276: 7376-82.
70. Knapen MH, Nieuwenhuijzen Kruseman AC, Wouters RS, Vermeer C, Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif Tissue Int 1998;63: 375-9.
71. Knapen MH, Schurgers LJ, Vermeer C, Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 2007;18: 963-72.
72. Kohlmeier M, Salomon A, Saupe J, Shearer MJ, Transport of vitamin K to bone in humans. J Nutr 1996;126(4 Suppl): 1192S-6S.
73. Koos R, Krueger T, Westenfeld R, Kuhl HP, Brandenburg V, Mahnken AH, Stanzel S, Vermeer C, Cranenburg EC, Floege J, Kelm M, Schurgers LJ, Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic valve calcification. Thromb Haemost 2009;101: 706-13.
74. Kuriyama S, Hitomi M, Yoshiji H, et al., Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules. Int J Oncol 2005;27: 505-11.
75. Lamon-Fava S, Sadowski JA, DavidsonKW, O'Brien ME, McNamara JR, Schaefer EJ, Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans. Am J Clin Nutr 1998;67: 1226-31.
76. Lev M, Milford AF, Effect of vitamin K depletion and restoration on sphingolipid metabolism in Bacteroides melaninogenicus. J Lipid Res 1972;13: 364-70.
77. Li J, Lin JC, Wang H, et al., Novel role of vitamin K in preventing oxidative injury to developing oligodendrocytes and neurons. J Neurosci 2003;23: 5816-26.
78. Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW, Identification of the gene for vitamin K epoxide reductase. Nature 2004;427: 521-44.
79. Li J, Wang H, Rosenberg PA, Vitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytes. J Neurosci Res 2009;87: 1987-2005.
80. Lian JB, Friedman PA, The vitamin K-dependent synthesis of γ-carboxyglutamic acid by bone microsomes. J Biol Chem 1978;253: 6623-6.
81. Lian JB, Stein GS, Stein JL, van Wijnen AJ, Regulated expression of the bone-specific osteocalcin gene by vitamins and hormones. Vitam Horm 1999;55: 443-509.
82. Liebman HA, Furie BC, Tong MJ, et al., Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984;310: 1427-31.
83. Liu G, Peacock M, Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int 1998;62: 286-9.
84. Liu W, Nakamura H, Yamamoto T, et al., Vitamin K2 inhibits the proliferation of HepG2 cells by up-regulating the transcription of p21 gene. Hepatol Res 2007;37: 360-5.
85. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G, Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386: 78-81.
86. Luukinen H, Kakonen SM, Pettersson K, Koski K, Laippala P, Lovgren T, Kivela SL, Vaananen HK, Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 2000;15: 2473-8.
87. MacDonald HM, McGuigan FE, Lanham-New SA, Fraser WD, Ralston SH, Reid DM, Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. Am J Clin Nutr 2008;87: 1513-20.
88. Manfioletti G, Brancolini C, Avanzi G, Schneider C, The protein encoded by a growth arrestspecific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 1993;13: 4976-85.
89. Matsumoto K, Okano J, Nagahara T, et al., Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition. Int J Oncol 2006;29: 1501-8.
90. McNinch AW, Orme RL, Tripp JH, Haemorrhagic disease of the newborn returns. Lancet 1983;1: 1089-90.
91. Miyazawa K, Yaguchi M, Funato K, et al., Apoptosis/differentiation-inducing effects of vitamin K2 on HL-60 cells: dichotomous nature of vitamin K2 in leukaemia cells. Leukemia 2001;15: 1111-7.
92. Mizuta T, Ozaki I, Eguchi Y, et al., The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study. Cancer 2006;106: 867-72.
93. 1, phthiocol and 2-methyl-1, 4-naphthoquinone. Proc Soc Exp Biol Med 1940;43: 125-8.
94. Murata K, Sakamoto A, Impairment of clathrin-mediated endocytosis via cytoskeletal change by epithelial to fibroblastoid conversion in HepG2 cells: a possible mechanism of des-gamma- carboxy prothrombin production in hepatocellular carcinoma. Int J Oncol 2008;33: 1149-55.
95. Murshed M, Schinke T, McKee MD, Karsenty G, Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 2004;165: 625-30.
96. Nanke Y, Kotake S, Ninomiya T, et al., Geranylgeranylacetone inhibits formation and function of human osteoclasts and prevents bone loss in tail-suspended rats and ovariectomized rats. Calcif Tissue Int 2005;77: 376-85.
97. Nawata H, Soen S, Takayanagi R, et al., Guidelines on the management and treatment of glucocorticoid- induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 2005;23: 105-9.
98. Nimptsch K, Rohrmann S, Linseisen J, Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPICHeidelberg). Am J Clin Nutr 2008;87: 985-92.
99. Nimptsch K, Rohrmann S, Nieters A, et al., Serum undercarboxylated osteocalcin as biomarker of vitamin K intake and risk of prostate cancer: A nested case-control study in the Heidelberg cohort of the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2009;18: 49-56.
100. Nimptsch K, Rohrmann S, Kaaks R, et al., Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin Nutr 2010;91: 1348-58.
101. O'Donnell C J, Shea MK, Price PA, Gagnon DR, Wilson PW, Larson MG, Kiel DP, Hoffmann U, Ferencik M, Clouse ME, Williamson LM, Cupples LA, Dawson-Hughes B, Booth SL, Matrix Gla protein is associated with risk factors for atherosclerosis but not with coronary artery calcification. Arterioscler Thromb Vasc Biol 2006;26: 2769-74.
102. Ogawa M, Nakai S, Deguchi A, et al., Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells. Int J Oncol 2007;31: 323-31.
103. Ohizumi H, Masuda Y, Nakajo S, et al., Geranylgeraniol is a potent inducer of apoptosis in tumor cells. J Biochem 1995;117: 11-3.
104. Ohsaki Y., Shirakawa H., Hiwatashi K., et al., Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Biosci Biotechnol Biochem 2006;70: 926-32.
105. Olson R.E., Chao J., Graham D., Bates M.W., Lewis J.H., Total body phylloquinone and its turnover in human subjects at two levels of vitamin K intake. Br J Nutr 2002;87: 543-53.
106. O'Shaughnessy D., Allen C., Woodcock T., Pearce K., Harvey J., Shearer M., Echis time, under-carboxylated prothrombin and vitamin K status in intensive care patients. Clin Lab Haematol 2003;25: 397-404.
107. Otsuka M., Kato N., Shao R.X., et al., Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation. Hepatology 2004;40: 243-51.
108. Ozaki I., Zhang H., Mizuta T., et al., Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor κB activation. Clin Cancer Res 2007;13: 2236-45.
109. Pineo G.F., Gallus A.S., Hirsh J., Unexpected vitamin K deficiency in hospitalized patients. Can Med Assoc J 1973;109: 880-3.
110. Price P.A., Otsuka A.S., Poser J.W., Kristaponis J., Raman N., Characterization of a γ-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci USA 1976;73: 1447-51.
111. Price P.A., Urist M.R., Otawara Y., Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 1983;117: 765-71.
112. Price P.A., Faus S.A., Williamson M.K., Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998;18: 1400-7.
113. Proudfoot D., Davies J.D., Skepper J.N., Weissberg P.L., Shanahan C.M., Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation 2002;106: 3044-50.
114. Raggi P., Shaw L.J., Berman D.S., Callister T.Q., Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004;43: 1663-69.
115. Reddi K., Henderson B., Meghji S., et al., Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine 1995;7: 287-90.
116. Rejnmark L., Vestergaard P., Charles P., Hermann A.P., Brot C., Eiken P., Mosekilde L., No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women. Osteoporos Int 2006;17: 1122-32.
117. Reynolds J.L., Joannides A.J., Skepper J.N., McNair R., Schurgers L.J., Proudfoot D., Jahnen-Dechent W., Weissberg P.L., Shanahan C.M., Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004;15: 2857-67.
118. Rimmer T., Treating the anorexia of cancer. Eur J Palliat Care 1998;5: 179-81. Rost S, Fregin A, Ivaskevicius V, et al., Mutations inVKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004;427: 537-41.
119. Rost S., Fregin A., Ivaskevicius V., et al., Mutations inVKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004;427: 537-41.
120. Sakai I., Hashimoto S., Yoda M., et al., Novel role of vitamin K2: A potent inducer of differentiation of various human myeloid leukaemia cell lines. Biochem Biophys Res Commun 1994;205: 1305-10.
121. Schurgers L.J., Vermeer C., Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis 2000;30: 298-307.
122. Schurgers L.J.,Vermeer C., Differential lipoprotein transport pathways of K-vitamins in healthy adults. Biochim Biophys Acta 2002;1570: 27-32.
123. Schurgers L.J., Geleijnse J.M., Grobbee D.E., Pols H.A.P., Hofman A., Witteman J.C.M., Vermeer C., Nutritional intake of vitamin K1 (Phylloquinone) and K2 (Menaquinone) in The Netherlands. J Nutr Environ Med 1999;9: 115-22.
124. Schurgers L.J., Aebert H., Vermeer C., Bültmann B., Janzen J., Oral anticoagulant treatment: friend or foe in cardiovascular disease? Blood 2004;104: 3231-2.
125. Schurgers L.J., Teunissen K.J., Knapen M.H., Kwaijtaal M., van Diest R., Appels A., Reutelingsperger C.P., Cleutjens J.P., Vermeer C., Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 2005;25: 1629-33.
126. Schurgers L.J., Spronk H.M., Skepper J.N., Hackeng T.M., Shanahan C.M., Vermeer C., Weissberg P.L., Proudfoot D., Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 2007a;5: 2503-11.
127. Schurgers L.J., Spronk H.M., Soute B.A., Schiffers P.M., DeMey J.G., Vermeer C., Regression of warfarin- induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007b;109: 2823-31.
128. 1 and natto-derivedmenaquinone-7. Blood 2007c;109: 3279-83.
129. Schurgers LJ, Cranenburg EC, Vermeer C, Matrix Gla-protein: the calcification inhibitor in need of vitamin K, Thromb Haemost 2008;100: 593-603.
130. Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, Vermeer C, Choukroun G, Massy ZA, The circulating inactive form of matrix Gla protein is a surrogate marker for vascular calcification in chronic kidney disease: A preliminary report. Clin J Am Soc Nephrol 2010;5: 568-75.
131. Shea MK, Booth SL, Massaro JM, et al., Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring study. Am J Epidemiol 2008;167: 313-20.
132. Shea MK, O'Donnell CJ, Hoffmann U, Dallal GE, Dawson-Hughes B, Ordovas JM, Price PA, Williamson MK, Booth SL, Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr 2009;89: 1799-807.
133. Shearer M.J., Vitamin K metabolism and nutriture. Blood Rev 1992;6: 92-104. Shearer MJ, Vitamin K. Lancet 1995;345: 229-234.
134. Shearer MJ, Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 2000;3: 433-8.
135. Shearer MJ, Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Rev 2009;23: 49-59.
136. Shearer MJ,Newman P, Metabolism and cell biology of vitamin K, Thromb Haemost 2008;100: 530-47.
137. Shearer MJ, Barkhan P, Webster GR, Absorption and excretion of an oral dose of tritiated vitamin K1 in man, Br J Haematol 1970;18: 297-308.
138. Shearer MJ, McBurney A, Barkhan P, Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man. Vitam Horm 1974;32: 513-42.
139. Shearer MJ, McCarthy PT, Crampton OE, Mattock MB, The assessment of human vitamin K status from tissue measurements. In: Suttie J, editor. Current advances in vitamin K research. NewYork: Elsevier Science; 1988. pp. 438-52.
140. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hiorns M, Donald AE, Deanfield J, Rees L, Shanahan CM, Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008;118: 1748-57.
141. Spronk HM, Soute BA, Schurgers LJ, Thijssen HH, De Mey JG, Vermeer C, Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res 2003;40: 531-7.
142. Stenberg LM, Nilsson E, Ljungberg O, et al., Synthesis of gamma-carboxylated polypeptides by alpha-cells of the pancreatic islets. Biochem Biophys Res Commun 2001;283: 454-9.
143. Stenflo J, From γ-carboxy-glutamate to protein C. J Thromb Haemost 2006;4: 2521-6.
144. O'Stenflo J, Fernlund P, Egan W, Roepstorff P, Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA 1974;71: 2730-3.
145. Stevenson M, Lloyd-Jones M, Papaioannou D, Vitamin K to prevent fractures in older women: systematic review and economic evaluation. Health Technol Assess 2009;13: iii-xi, 1-134.
146. Sundaram KS, Lev M, Warfarin administration reduces synthesis of sulfatides and other sphingolipids in mouse brain. J Lipid Res 1988;29: 1475-9.
147. Sundaram KS, Lev M, Regulation of sulfotransferase activity by vitamin K in mouse brain. Arch Biochem Biophys 1990;277: 109-13.
148. Sundaram KS, Fan JH, Engelke JA, et al., Vitamin K status influences brain sulfatide metabolism in young mice and rats. J Nutr 1996;126: 2746-51.
149. Suttie JW, Vitamin K and human nutrition. J Am Diet Assoc 1992;92: 585-90. Suttie JW, The importance of menaquinones in human nutrition. Annu Rev Nutr 1995;15: 399-417.
150. Suttie JW, Vitamin K in health and disease. Boca Raton: CRC Press; 2009. 224 pp.
151. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD, Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 1994;9: 1591-5.
152. Szulc P, Chapuy MC, Meunier PJ, Delmas PD, Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 1996;18: 487-8.
153. 2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR, J Biol Chem 2003;278: 43919-27.
154. Taggart WV, Matschiner JT, Metabolism of menadione-6,7-3H in the rat. Biochemistry 1969;8: 1141-6.
155. Taper HS, de Gerlache J, Lans M, et al., Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment. Int J Cancer 1987;40: 575-9.
156. Thane CW, Bolton-Smith C, Coward WA, Comparative dietary intake and sources of phylloquinone (vitamin K1) among British adults in 1986-7 and 2000-1. Br J Nutr 2006;96: 1105-15.
157. Thane CW, Paul AA, Bates CJ, Bolton-Smith C, Prentice A, Shearer MJ, Intake and sources of phylloquinone (vitamin K1): variation with socio-demographic and lifestyle factors in a national sample of British elderly people. Br J Nutr 2002;87: 605-13.
158. Thierry MJ, Suttie JW, Effect of warfarin and the chloro analog of vitamin K on phylloquinone metabolism. Arch Biochem Biophys 1971;147: 430-5.
159. Thijssen HHW, Drittij-Reijnders MJ, Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4. Br J Nutr 1994;72: 415-25.
160. Thijssen HHW, Drittij-Reijnders MJ, Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4. Br J Nutr 1996;75: 121-7.
161. Thomas DD, Krzykowski KJ, Engelke JA, et al., Exocrine pancreatic secretion of phospholipid, menaquinone-4, and caveolin-1 in vivo. Biochem Biophys Res Commun 2004;319: 974-9.
162. Topp H, Iontcheva V, Schoch G, Renal excretion of -carboxyglutamic acid and metabolic rate in 3-18 year old humans. Amino Acids 1998;14: 371-7.
163. Tsugawa N, Shiraki M, Suhara Y, Kamao M, Ozaki R, Tanaka K, Okano T, Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Miner Metab 2008;26: 79-85.
164. Ueland T, Gullestad L, Dahl CP, et al., Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis. J Intern. Med. "Accepted Article": doi:10.1111/j.1365-2796.2010.02264.x. J
165. Usui Y, Tanimura H, Nishimura N, Kobayashi N, Okanoue T, Ozawa K, Vitamin K concentrations in the plasma and liver of surgical patients. Am J Clin Nutr 1990;51: 846-52.
166. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD, Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 1997;82: 719-24.
167. Vermeer C, Shearer MJ, Zittermann A, et al., Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr 2004;43: 325-35.
168. Viegas CSB, Simes DC, Laize V, Williamson MK, Price PA, Cancela ML, Gla-rich protein (GRP), a new vitamin K-dependent protein identified from sturgeon cartilage and highly conserved in vertebrates. J Biol Chem 2008;283: 36655-64.
169. von Kries R, Becker A, Göbel U, Vitamin K in the newborn: influence of nutritional factors on acarboxyprothrombin detectability and factor II and VII clotting activity. Eur J Pediatr 1987;146: 123-7.
170. von Kries R, Shearer MJ, Göbel U, Vitamin K in infancy. Eur J Pediatr 1988;147: 106-12.
171. Wajih N, Borras T, Xue W, Hutson SM, Wallin R, Processing and transport of matrix gammacarboxyglutamic acid protein and bone morphogenetic protein-2 in cultured human vascular smooth muscle cells: evidence for an uptake mechanism for serum fetuin. J Biol Chem 2004;279: 43052-60.
172. Wallin R, Cain D, Sane DC, Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells - a cell system which resembles the system in bone cells. Thromb Haemost 1999;82: 1764-7.
173. Wallin R, Cain D, Hutson SM, Sane DC, Loeser R, Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2). Thromb Haemost 2000;84: 1039-44.
174. Wang Z, Wang M, Finn F, et al., The growth inhibitory effects of vitamins K and their actions on gene expression. Hepatology 1995;22: 876-82.
175. Wei G, Wang M, Carr BI, Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-jun NH-2-terminal kinase pathways. J Cell Physiol 2010;224: 112-9.
176. Westenfeld R, Krüger T, Schlieper G, Cranenburg E, Heidenreich S, Holzmann S, Vermeer C, Ketteler M, Floege J, Schurgers LJ, Vitamin K2 supplementation reduces the elevated inactive form of the calcification inhibitor matrix Gla protein in hemodialysis patients. American Society of Nephrology (ASN). 2008; TH-FC044 (Abstract).
177. Yaguchi M, Miyazawa K, Katagiri T, et al., Vitamin K2 and its derivatives induce apoptosis in leukaemia cells and enhance the effect of all-trans retinoic acid. Leukemia 1997;11: 779-87.
178. Yaguchi M, Miyazawa K, Otawa M, et al., Vitamin K2 selectively induces apoptosis of blastic cells in myelodysplastic syndrome: flow cytometric detection of apoptotic cells using APO2.7 monoclonal antibody. Leukemia 1998;12: 1392-7.
179. Yoshiji H, Kuriyama S, Noguchi R, et al., Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression. J Hepatol 2005;42: 687-93.
180. Yoshiji H, Noguchi R, Toyohara M, et al., Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma. J Hepatol 2009;51: 315-21.